Short Wave Short Wave

How science is taking tripping mainstream

May 6, 2026 · 12m

Summary

NPR’s Shortwave explores the scientific renaissance of psychedelic drugs, tracing their shift from counterculture icons to potential psychiatric treatments. Host Regina Barber and guest John Hamilton discuss how researchers at Imperial College London, including Robin Carhart-Harris and David Nutt, pioneered studies on psilocybin for depression and PTSD. The episode highlights the role of ketamine in opening regulatory doors and details the therapeutic protocols involving music and guided sessions.

Topics discussed

Tiny Desk Contest Tour promotion The shifting landscape of psychedelic research Sponsor messages from Washington Wise and NetSuite Key researchers at Imperial College London Brain science: Default mode network and acceptance Ketamine's role in opening the door for psychedelics The 'set and setting' of psychedelic therapy Outro, credits, and Up First preview

More from Short Wave

This gas station drug acts like opioids. It’s getting harder to buy
Nov 20, 2026
How a viral video gave a huge boost to new gene therapy
Nov 18, 2026
How bird poop and manta rays sustain a pristine coral reef
Nov 17, 2026
Are your body clocks off? Meet ‘circadian depression’
Nov 16, 2026
AI could help hospitals diagnose PTSD in real time
Nov 13, 2026
Listen ad-free on Castria